Scorpius Inc.

AMEX: SCPX · Real-Time Price · USD
0.04
-0.01 (-12.47%)
At close: May 01, 2025, 2:15 PM
0.04
0.00%
After-hours: May 01, 2025, 02:15 PM EDT

Company Description

Scorpius Holdings Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization.

The company provides analytical testing, downstream process development, formulation optimization and development, and clinical biomanufacturing services to pharmaceutical and biotech companies.

It is also involved in the provision of pre-clinical and product development; chemistry, manufacturing, and control analytical support; and bioassays.

The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024.

Scorpius Holdings, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.

Scorpius Inc.
Scorpius  Inc. logo
Country United States
IPO Date Jul 24, 2013
Industry Biotechnology
Sector Healthcare
Employees 82
CEO Jeffrey Alan Wolf J.D.

Contact Details

Address:
627 Davis Drive
Morrisville, North Carolina
United States
Website https://www.scorpiusbiologics.com

Stock Details

Ticker Symbol SCPX
Exchange AMEX
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001476963
CUSIP Number n/a
ISIN Number US42237K4094
Employer ID 26-2844103
SIC Code 2834

Key Executives

Name Position
Jeffrey Alan Wolf J.D. Founder, Chairman, President & Chief Executive Officer
Joe Payne President & Chief Operating Officer of Scorpius BioManufacturing
William L. Ostrander Chief Financial Officer, Controller & Secretary
Colonel George E. Peoples Jr., F.A.C.S., M.D. Chief Medical Advisor
Dr. Justin Stebbing FRCP, FRCPath, M.A., M.D., Ph.D. Chief Medical Advisor and Member of Scientific & Clinical Advisory Board
Nicole Temple Senior Manager & Head of Program Management

Latest SEC Filings

Date Type Title
May 01, 2025 8-K Current Report
May 01, 2025 25-NSE Filing
Apr 30, 2025 10-K Annual Report
Apr 28, 2025 RW Filing
Apr 21, 2025 8-K Current Report
Apr 01, 2025 NT 10-K Filing
Mar 28, 2025 8-K Current Report
Mar 20, 2025 8-K Current Report
Mar 13, 2025 8-K Current Report
Mar 12, 2025 3 Filing